We have shown that ex vivo DC generation and maturation from monocytes of breast cancer patients is optimally possible in a system of 4 cytokines including IFN-α, which can potentially be used in DC immunotherapy of operable breast cancer patients. Here, IFNA1 is linked to breast carcinoma.